ISPOR 23rd Annual International Meeting

Symposium

Monday, May 21, 2018 12:30PM – 1:30PM

21st Century Cures Act and the Future of Real World Evidence

Moderated by David Thompson, Senior Vice President, Real World & Late Phase

Forum Presentation

Monday, May 21, 2018 6:15 – 7:15pm

Good Practices for ID and Use of Health State Utilities in Cost-Effectiveness Decision Modeling – Interim Results of an ISPOR Task Force

Bruce Crawford, MPH, MA, Vice President, Real World Evidence, APAC

Posters

Monday, May 21, 2018 8:30 AM - 2:00 PM

Quantifying the Monitoring Burden of Multiple Sclerosis (MS) Treatment in the United Kingdom (UK): Feasibility Phase for an Observational Time and Motion (T&M) Study

Erwin De Cock, Principal, Real-World & Late Phase

Monday, May 21, 2018 3:30 PM - 7:30 PM

An Algorithmic Approach to Optimal Study Design for Outcomes Research

David Thompson, Senior Vice President, Real World & Late Phase

Tuesday, May 22, 2018 8:30 AM – 2:00 PM

Simultaneous Development of Patient-Reported Outcome Measures for Masseter Muscle Hypertrophy in an Asia Population

Bruce Crawford, MPH, MA, Vice President, Real World Evidence, APAC

Tuesday, May 22, 2018 8:30 AM - 2:00 PM

Characterization of Drug Utilization Studies (DUS) Submitted to The European Union (EU) Electronic Register of Post-Authorisation Studies (PAS)

Lucía Palacios, B.S. (Hons), PhD, Project Manager, Real-World & Late Phase

Tuesday, May 22, 2018 8:30 AM - 2:00 PM

Characterization of Observational Phase IV Studies Submitted to clinicaltrials.gov Between 2007 and 2017

Lucía Palacios, B.S. (Hons), PhD, Project Manager, Real-World & Late Phase